UBS Group AG - UNICYCIVE THERAPEUTICS INC ownership

UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 16 filers reported holding UNICYCIVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of UNICYCIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$617
-58.8%
718
-38.6%
0.00%
Q2 2023$1,496
+49.6%
1,169
-1.8%
0.00%
Q3 2022$1,000
-75.0%
1,190
-73.5%
0.00%
Q2 2022$4,000
-63.6%
4,491
-14.8%
0.00%
Q4 2021$11,000
+450.0%
5,273
+749.1%
0.00%
Q3 2021$2,0006210.00%
Other shareholders
UNICYCIVE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ayrton Capital LLC 76,645$64,0000.10%
Nantahala Capital Management 729,680$606,0000.03%
Board of Trustees of The Leland Stanford Junior University 247,583$205,0000.01%
TANDEM CAPITAL MANAGEMENT CORP /ADV 15,500$13,0000.01%
FineMark National Bank & Trust 15,625$13,0000.00%
Frontier Wealth Management LLC 18,800$16,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 26,109$21,0000.00%
Citadel Advisors 15,210$13,0000.00%
Tower Research Capital LLC (TRC) 5,167$4,0000.00%
View complete list of UNICYCIVE THERAPEUTICS INC shareholders